Portal de Periódicos da CAPES

Down's Syndrome, Aging, and Alzheimer's Disease: A Clinical Review*

1982; Wiley; Volume: 396; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1982.tb26840.x

1749-6632

Ira T. Lott,

Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Annals of the New York Academy of SciencesVolume 396, Issue 1 p. 15-27 Down's Syndrome, Aging, and Alzheimer's Disease: A Clinical Review* IRA T. LOTT, IRA T. LOTT Eunice Kennedy Shriver Center for Mental Retardation Waltham, Massachusetts 02254 Neurology Service Massachusetts General Hospital Harvard Medical School Boston, Massachusetts 02114Search for more papers by this author IRA T. LOTT, IRA T. LOTT Eunice Kennedy Shriver Center for Mental Retardation Waltham, Massachusetts 02254 Neurology Service Massachusetts General Hospital Harvard Medical School Boston, Massachusetts 02114Search for more papers by this author First published: October 1982 https://doi.org/10.1111/j.1749-6632.1982.tb26840.xCitations: 66 * Supported, in part, by National Institutes of Health Grants HD 05515 and HD 04147. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Hook, E.B. & A. Lindsjö. 1978. Down syndrome in live births by single-year maternal age interval in a Swedish study: Comparison with results from a New York state study. Am. J. Hum. Genet. 30: 19–27. CASPubMedWeb of Science®Google Scholar 2 Holmes, L.B. 1978. Genetic counseling for the older pregnant woman: New data and questions. New Engl. J. Med. 298: 1419–1420. 10.1056/NEJM197806222982511 CASPubMedWeb of Science®Google Scholar 3 Collmann, R.D. & A. Stoller. 1969. Shift of child birth to younger mothers, and its effect on the incidence of mongolism in Victoria, Australia. J. Ment. Defic. Res. 13: 13–19. 10.1111/j.1365-2788.1969.tb01062.x CASPubMedWeb of Science®Google Scholar 4 Adams, M.M., J.D. Erickson, P.M. Layde & G.P. Oakley. 1981. Down's syndrome. Recent trends in the United States. JAMA 246: 758–760. 10.1001/jama.246.7.758 CASPubMedWeb of Science®Google Scholar 5 Oster, J. 1953. Mongolism. A clinicogenealogical investigation comprising 526 mongols living on Sealand and neighbouring islands in Denmark. Danish Science Press Ltd., Copenhagen . Google Scholar 6 Mikkelsen, M. 1981. New aspects of a well-known syndrome (Down syndrome—mongolism). Eur. J. Pediat. 136: 5–7. 10.1007/BF00441703 CASPubMedWeb of Science®Google Scholar 7 Koch, G. 1975. Conference on Down's syndrome (mongolism): Research, prevention, and management. Anaheim, CA, 1973. R. Koch & F.F. Cruz, Eds. Brunner/Mazel. New York . Google Scholar 8 Carr, J. 1975. Young children with Down's syndrome; Their development, upbringing, and effect on their families. Butterworth. London . Google Scholar 9 Dameron, L.E. 1963. Development of intelligence of infants with mongolism. Child Dev. 34: 733–738. CASPubMedWeb of Science®Google Scholar 10 Griffiths, M.I. 1976. Development of children with Down's syndrome. Physiotherapy 62: 11–15. CASPubMedGoogle Scholar 11 Share, J., A. Webb & R. Koch. 1961. A preliminary investigation of the early development status of mongoloid infants. Am. J. Ment. Defic. 66: 238–241. Web of Science®Google Scholar 12 Connolly, J. A. 1978. Intelligence levels of Down's syndrome children. Am. J. Ment. Defic. 83: 193–196. CASPubMedWeb of Science®Google Scholar 13 Ropper, A.H. & R.S. Williams. 1980. Relationship between plaques, tangles, and dementia in Down syndrome. Neurology 30: 639–644. 10.1212/WNL.30.6.639 PubMedWeb of Science®Google Scholar 14 Wisniewski, K., J. Howe & D.G. Williams. 1978. Precocious aging and dementia in patients with Down's syndrome. Biol. Psychiat. 13: 619–627. CASPubMedWeb of Science®Google Scholar 15 Loesch-Modzewski, I.D. 1968. Some aspects of the neurology of Down's syndrome. J. Ment. Defic. Res. 12: 237–246. PubMedGoogle Scholar 16 Owens, D., J.C. Dawson & S. Lowsin. 1971. Alzheimer's disease in Down's syndrome. Am. J. Ment. Defic. 75: 606–612. PubMedWeb of Science®Google Scholar 17 Dalton, A.J., D.R. Crapper & G.R. Schlotterer. 1974. Alzheimer's disease in Down's syndrome visual retention deficits. Cortex 10: 366–377. 10.1016/S0010-9452(74)80029-8 PubMedGoogle Scholar 18 Nakamura, H. 1961. Nature of institutionalized adult mongoloid intelligence. Am. J. Ment. Defic. 66: 456–458. CASPubMedWeb of Science®Google Scholar 19 Francis, S.H. 1970. Behavior of low-grade institutionalized mongoloids: Changes with age. Am. J. Ment. Defic. 75: 92–101. CASPubMedWeb of Science®Google Scholar 20 Adams, R.D. & R.I. Sidman. 1968. Introduction to Neuropathology. McGraw Hill. New York . Google Scholar 21 Jacob, H. 1956. Lubarsch-Henke Handb. der Spez. path. Anat. und Histol. 13: 82. Google Scholar 22 Crome, L. & J. Stern. 1972. Pathology of Mental Retardation. Williams & Wilkins. Baltimore .pp. 200–224. Google Scholar 23 Benda, C.E. 1969. Down's Syndrome, 2nd edit. Grune and Stratton. New York . Google Scholar 24 Roche, A.F., P.J. Roche & A.B. Lewis. 1972. The cranial base in trisomy 21. J. Ment. Defic. Res. 16: 7–20. 10.1111/j.1365-2788.1972.tb01566.x CASPubMedWeb of Science®Google Scholar 25 Struwe, F. 1929. Histopathology Untersuchungen uber Entstehung und Wesen der senile Plaques z. ges. Neurol. Psychiat. 122: 291–307. 10.1007/BF02876635 Web of Science®Google Scholar 26 Bertrand, I. & D. Koffas. 1946. Cas d'idiotie mongolienne adulte avec nombreuses plaques seniles et concretions calcarires pallidales. Rev. Neurol. 78: 338–345. Web of Science®Google Scholar 27 Jervis, G. 1948. Early senile dementia in mongoloid idiocy. Am. J. Psychiat. 105: 102–106. 10.1176/ajp.105.2.102 CASPubMedWeb of Science®Google Scholar 28 Burger, P.C. & F.S. Vogel. 1973. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am. J. Pathol. 73: 457–468. CASPubMedWeb of Science®Google Scholar 29 Ellis, W.G., J.R. McCulloch & C.L. Corley. 1974. Presenile dementia in Down's syndrome — ultrastructural identify with Alzheimer's disease. Neurology 24: 101–106. 10.1212/WNL.24.2.101 CASPubMedWeb of Science®Google Scholar 30 Wisniewski, K., J.M. Cobill, C.B. Wilcox, E.A. Caspary, D.G. Williams & H.M. Wisniewski. 1979. T lymphocytes in patients with Down's syndrome. Biol. Psychiat. 14: 463–471. CASPubMedWeb of Science®Google Scholar 31 Solitare, G.B. & J.B. Lamarche. 1966. Alzheimer's disease and senile dementia as seen in mongoloids. Am. J. Ment. Defic. 70: 840–848. CASPubMedWeb of Science®Google Scholar 32 Neumann, M.A. 1967. Langdon-Down syndrome and Alzheimer's disease. J. Neuropathol. 26: 149. PubMedWeb of Science®Google Scholar 33 Haberland, C. 1969. Alzheimer's disease in Down's syndrome. Acta Neurol. Belg. 69: 369–380. CASPubMedGoogle Scholar 34 Olson, M.I. & C-M. Shaw. 1969. Presenile dementia and Alzheimer's disease in mongolism. Brain 92: 147–156. 10.1093/brain/92.1.147 CASPubMedWeb of Science®Google Scholar 35 Schochet, S.S., P.W. Lampert & W.F. McCormick. 1973. Neurofibrillary tangles in patients with Down's syndrome. Acta Neuropathol. 23: 342–346. 10.1007/BF00687465 PubMedWeb of Science®Google Scholar 36 Malamud, N. 1972. Neuropathology of Organic Brain Syndromes Associated with Aging. In Aging and the Brain. C.M. Gaitz, Ed. Plenum. New York . 10.1007/978-1-4684-8503-5_6 Google Scholar 37 Crapper, D.R., A.J. Dalton & M. Skopitz. 1975. Alzheimer's degeneration in Down syndrome. Arch. Neurol. 33: 618–623. 10.1001/archneur.1975.00490510074006 Google Scholar 38 Ball, M.J. & K. Nuttall. 1980. Neurofibrillary tangles, granulovacuolar degeneration and neuron loss in Down syndrome: Quantitative comparison with Alzheimer's dementia. Ann. Neurol. 7: 462–465. 10.1002/ana.410070512 CASPubMedWeb of Science®Google Scholar 39 Suetsugu, M. & P. Mehraein. 1980. Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome. Acta Neuropathol. 50: 207–210. 10.1007/BF00688755 PubMedWeb of Science®Google Scholar 40 Mehraein, P., M. Yamada, & E. Tarnowski-Dziduszko. 1975. Quantitative study on dendrites and dendritic spines in Alzheimer's disease and senile dementia. In Advances in Neurology. G.W. Kreutzberg, Ed. 12: 453–458. CASPubMedWeb of Science®Google Scholar 41 Godinova, A.M. 1963. Electroencephalographic changes in Down's syndrome. Zb. Neuropat. Psikhiat 63: 1058. CASPubMedGoogle Scholar 42 Hirai, T. & S. Izawa. 1964. EEG study of mongolism. Psychiatr. Neurol. Jap. 66: 166. CASPubMedGoogle Scholar 43 Tangye, S.R. 1979. The EEG and incidence of epilepsy in Down's syndrome. J. Ment. Defic. Res. 23: 17–24. 10.1111/j.1365-2788.1979.tb00849.x PubMedWeb of Science®Google Scholar 44 Callner, D.A., R.E. Dustman, J.A. Madsen, T. Schenkenberg & E.C. Beck. 1978. Life span changes in the average evoked responses of Down's syndrome and non-retarded persons. Am. J. Ment. Defic. 82: 398–405. CASPubMedWeb of Science®Google Scholar 45 Bigum, H.B., R.E. Dustman & E.C. Beck. 1970. Visual and somatosensory evoked responses from mongoloid and normal children. Electroencephalogr. Clin. Neurophysiol. 28: 476–585. 10.1016/0013-4694(70)90199-9 Web of Science®Google Scholar 46 Glidden, J.B., J. Busk & G.C. Galbraith. 1975. Visual evoked responses as a function of light intensity in Down's syndrome and non-retarded subjects. Psychophysiology 12: 416–422. 10.1111/j.1469-8986.1975.tb00015.x PubMedWeb of Science®Google Scholar 47 Barnet, A.B., E.S. Ohlrich & B.L. Shanks. 1971. EEG evoked responses to repetititve auditory stimulation in normal and Down's syndrome infants. Develop. Med. Child. Neurol. 13: 321–329. 10.1111/j.1469-8749.1971.tb03269.x CASPubMedWeb of Science®Google Scholar 48 Straumanis, J.J., C. Shagass & D.A. Overton. 1972. Auditory evoked responses in young adults with Down's syndrome and idiopathic mental retardation. Biol. Psychiat. 1: 75–79. Google Scholar 49 Straumanis, J.J., C. Shagass & D.A. Overton. 1973. Somatosensory evoked responses in Down's syndrome. Arch. Gen. Psychiat. 29: 544–549. 10.1001/archpsyc.1973.04200040086014 PubMedWeb of Science®Google Scholar 50 Carter, C.O. 1958. A life table for mongols in Victoria. J. Ment. Defic. Res. 7: 53. Google Scholar 51 Hann, H.L., J.C. Deacon & W.T. London. 1979. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome. Am. J. Ment. Defic. 84: 245. CASPubMedWeb of Science®Google Scholar 52 Nishida, Y., Y. Sano, I. Akaoka. 1978. Abnormal serum immunoglobulin levels in Down's syndrome patients. Am. J. Ment. Defic. 83: 16–20. CASPubMedWeb of Science®Google Scholar 53 Burgio, G.R., A.G. Ugazio, L. Nespoli, A.F. Marcioni, A.M. Bottelli & F. Pasquali. 1975. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur. J. Immunol. 5: 600–603. 10.1002/eji.1830050904 CASPubMedWeb of Science®Google Scholar 54 Seger, R., G. Buchinger & J. Stroder. 1977. On the influence of age on immunity in Down's syndrome. Eur. J. Pediat. 124: 77. 10.1007/BF00477543 CASPubMedWeb of Science®Google Scholar 55 Whittingham, S., D.L.B. Sharma, D.B. Pitt & I.R. Mackay. 1977. Stress deficiency of the T-lymphocyte system exemplified by Down syndrome. Lancet i: 163–166. 10.1016/S0140-6736(77)91763-9 CASGoogle Scholar 56 Levin, S., E. Nir & B.M. Mogilner. 1975. T system immune-deficiency in Down's syndrome. Pediatrics 56: 123. PubMedWeb of Science®Google Scholar 57 Ugazio, A.G., R. Maccario, M. Duse & G.R. Burgio. 1977. T lymphocytes deficiency in Down's syndrome. Lancet i: 1062. 10.1016/S0140-6736(77)91304-6 CASGoogle Scholar 58 Epstein, L.B. & C.J. Epstein. 1976. J. Infect. Dis. 133: A56–A62. 10.1093/infdis/133.Supplement_2.A56 PubMedWeb of Science®Google Scholar 59 Declercq, E. 1978. Increased resistance of trisomic-21 cells to virus replication: Role of Interferon. Virology 86: 276–280. 10.1016/0042-6822(78)90028-4 CASPubMedWeb of Science®Google Scholar 60 Weksler, M.E. 1980. The immune system and the aging process in man. Proc. Soc. Exp. Biol. Med. 165: 200–205. 10.3181/00379727-165-40958 CASPubMedWeb of Science®Google Scholar 61 Tam, C.F. & R.L. Walford. 1980. Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging and normal humans and patients with Down's syndrome. J. Immunol. 125: 1665–1670. CASPubMedWeb of Science®Google Scholar 62 Naeim, F. & R.L. Walford. 1980. Disturbance of redistribution of surface membrane receptors on peripheral mononuclear cells of patients with Down's syndrome and of aged individuals. J. Gerontol. 35: 650–655. 10.1093/geronj/35.5.650 CASPubMedWeb of Science®Google Scholar 63 Woda, B.A. & J.D. Feldman. 1979. Density of surface immunoglobulin and capping on rat B lymphocytes. 1. Changes with aging. J. Exp. Med. 149: 416–423. 10.1084/jem.149.2.416 CASPubMedWeb of Science®Google Scholar 64 Cupples, C.G. & Y.H. Tan. 1977. Effect of human interferon preparations on lympho-blastogenesis in Down's syndrome. Nature 267: 165–167. 10.1038/267165a0 CASPubMedWeb of Science®Google Scholar 65 Gurari-Rotman, D., M. Revel, B. Tartakovsky, S. Segal, T. Hahn & S. Levin. 1978. Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon. FEBS Lett. 94: 187–190. 10.1016/0014-5793(78)80934-X CASPubMedWeb of Science®Google Scholar 66 Epstein, L.B. 1980. T-lymphocyte function and sensitivity to interferon in trisomy 21. Cell Immunol. 51: 303–318. 10.1016/0008-8749(80)90262-2 CASPubMedWeb of Science®Google Scholar 67 McGirr, E.M. & I.P.C. Murray. 1956. Thyrotoxicosis in a mongol. J. Clin. Endocrinol. 16: 160–163. 10.1210/jcem-16-1-160 CASPubMedWeb of Science®Google Scholar 68 Esen & Mantner. 1957. Hypo- and hyperthyroidism in mongolism. Arch. Pediat. 74: 291–301. CASPubMedGoogle Scholar 69 Diggle, S.H. & R.S. Weetch. 1958. Thyrotoxicosis in a mongol. Proc. Roy. Soc. Med. 51: 293–294. Web of Science®Google Scholar 70 Johnson, J.E. & A.R. Cook. 1962. Hyperthyroidism in patient with mongolism. J. Clin. Endocrinol. 22: 665–668. 10.1210/jcem-22-6-665 PubMedWeb of Science®Google Scholar 71 Kay, C.J. & V.M. Esselborn. 1963. Hyperthyroidism and mongolism. Am. J. Dis. Child. 106: 411–414. 10.1001/archpedi.1963.02080050413010 CASPubMedWeb of Science®Google Scholar 72 Azizi, F., H. Chandler, Bozogzadeh & L.E. Braverman. 1974. The occurrence of hyperthyroidism in patients with Down's syndrome. Johns Hopkins Med. J. 134: 303–305. CASPubMedWeb of Science®Google Scholar 73 Aarskog, D. 1969. Autoimmune thyroid disease in children with mongolism. Arch. Dis. Child. 44: 454–460. 10.1136/adc.44.236.454 CASPubMedWeb of Science®Google Scholar 74 Baxter, R.G., R.G. Larkins, F.I.R. Martin, P. Heyma, K. Myles & L. Ryan. 1975. Down syndrome and thyroid functions in adults. Lancet ii: 794–796. 10.1016/S0140-6736(75)80007-9 CASGoogle Scholar 75 Murdoch, J.C., W.A. Ratcliffe, D.G. McLarty, J.C. Rodger & J.G. Ratcliffe. 1977. Thyroid functions in adults with Down's syndrome. J. Clin. Endocrinol. 44: 453–458. 10.1210/jcem-44-3-453 CASPubMedWeb of Science®Google Scholar 76 Simon, A., C. Ludwig, J.W. Gotman & G.H. Crook. 1954. Metabolic studies in mongolism, serum protein-bound iodine, cholesterol, and lipoprotein. Am. J. Psychiatr. 111: 139–145. 10.1176/ajp.111.2.139 CASPubMedWeb of Science®Google Scholar 77 Friedman, A. 1955. Radioiodine uptake in children with mongolism. Pediatrics 16: 55–56. CASPubMedWeb of Science®Google Scholar 78 Pearse, J.J., M. Reiss & R.T. Suwahski. 1963. J. Clin. Endocrinol. 23: 311–312. 10.1210/jcem-23-3-311 CASPubMedWeb of Science®Google Scholar 79 Sacena, K.M. & C.V. Pryles. 1965. Thyroid function in mongolism. J. Pediat. 67: 363–370. 10.1016/S0022-3476(65)80396-1 Web of Science®Google Scholar 80 Sare, Z., R.H.A. Ruvalcaba & J.C. Kelley. 1978. Prevalence of thyroid disorder in Down syndrome. Clin. Genet. 14: 154–158. 10.1111/j.1399-0004.1978.tb02121.x CASPubMedWeb of Science®Google Scholar 81 Fialkow, P.J. 1970. Thyroid autoimmunity and Down's syndrome. Ann. N.Y. Acad. Sci. 171: 500–511. 10.1111/j.1749-6632.1970.tb39359.x Web of Science®Google Scholar 82 Sawin, C.T., D. Chopra, F. Azizi, J. Mannix & P. Bacharach. 1979. The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA 242: 245–250. PubMedWeb of Science®Google Scholar 83 Murdoch, J.C., C.A. Giles, J.K. Grant & J.C. Ratcliff. 1979. Hypothalamic-pituitary-adrenocortical function in adults with Down's syndrome. J. Ment. Defic. Res. 23: 157–162. 10.1111/j.1365-2788.1979.tb00990.x CASPubMedWeb of Science®Google Scholar 84 Murdoch, J.C. & J.H. Evans. 1978. An objective in vitro study of aging in the skin of patients with Down's syndrome. J. Ment. Defic. Res. 22: 131–135. 10.1111/j.1365-2788.1978.tb00969.x CASPubMedWeb of Science®Google Scholar 85 Edwards, J.H. 1978. Skin age in Down's syndrome: A note on the findings of Murdoch and Evans. J. Ment. Defic. Res. 22: 223. 10.1111/j.1365-2788.1978.tb00979.x CASPubMedWeb of Science®Google Scholar 86 Sylvester, P.E. 1974. Aortic and pulmonary valve fenestrations as aging indices in Down's syndrome. J. Ment. Defic. Res. 18: 367–376. 10.1111/j.1365-2788.1974.tb01247.x CASPubMedWeb of Science®Google Scholar 87 Robb, R.M. & A. Marchevsky. 1978. Pathology of the lens in Down's syndrome. Arch. Ophthalmol. 96: 1039–1042. 10.1001/archopht.1978.03910050559014 CASPubMedWeb of Science®Google Scholar 88 Ingersheimer, J. 1951. The relationship of lenticular changes to mongolism. Trans. Am. Ophthalmol. Soc. 45: 595–624. Google Scholar 89 Tan, Y.H., J. Tischfield & F.H. Ruddle. 1973. The linkage of genes for the human interferon induced antiviral protein and indophenol oxidase-B traits to chromosome G-21. J. Exp. Med. 137: 317–330. 10.1084/jem.137.2.317 CASPubMedWeb of Science®Google Scholar 90 Sichitiu, S., P.M. Sinet, J. Lejeune & J. Frezal. 1974. Sur dosage de la forme dimérique de l'indophenoloxydase dans la trisomie 21, secondaire au surdosage gènique. Humangenetik 26: 65–72. 10.1007/BF00295684 Web of Science®Google Scholar 91 Sinet, P.M., D. Allard, J. Lejeune & H. Jerome. 1974. Augmentation d'activite de la superoxyde dismutase dans la trisomie pour 6 chromosome 21. C. R. Acad. Sci. 278: 3267–3270. CASPubMedWeb of Science®Google Scholar 92 Gilles, L., C. Ferradini, J. Foos, J. Pucheault, D. Allard, P.M. Sinet & H. Jerome. 1976. The estimation of red cell superoxyde dismutase activity by pulse radiolysis in normal and trisomy 21 subjects. FEBS Lett. 69: 55–58. 10.1016/0014-5793(76)80652-7 CASPubMedWeb of Science®Google Scholar 93 Crosti, N., A. Serra, A. Rigo & P. Viglino. 1976. Dosage effect of SOD-A gene in 21 trisomie cells. Hum. Genet. 31: 197–202. 10.1007/BF00296146 CASPubMedWeb of Science®Google Scholar 94 Sinet, P.M. F. Lavalle, A.M. Michelson & H. Jerome. 1975. Superoxide dismutase activities of blood platelets in trisomy 21. Biochem. Biophys. Res. Commun. 67: 904–909. 10.1016/0006-291X(75)90762-7 CASPubMedWeb of Science®Google Scholar 95 Feaster, W.W., L.W. Kwok & C.S. Epstein. 1977. Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21. Am. J. Hum. Genet. 29: 563–570. CASPubMedWeb of Science®Google Scholar 96 Sinex, F.M. 1976. Genetic mechanisms of aging. In Handbook on Aging. J. Birren, Ed. Van Nostrand Reinhold. Google Scholar 97 Sinet, P.-M., J. Lejeune & H. Jerome. 1979. Trisomy 21 glutathione peroxidase. Hexose-nonphosphate shunt and I.Q. Life Sci. 24: 29–34. 10.1016/0024-3205(79)90276-5 CASPubMedWeb of Science®Google Scholar 98 Segal, D.J. & E.E. McCoy. 1974. Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblasts cultures. J. Cell Comp. Physiol. 83: 85–90. 10.1002/jcp.1040830112 CASPubMedWeb of Science®Google Scholar 99 Wisniewski, K., G.A. Jervis & R.C. Moretz. 1979. Alzheimer's neurofibrillary tangles in diseases other than senile and presenile dementia. Ann. Neurol. 5: 288–294. 10.1002/ana.410050311 PubMedWeb of Science®Google Scholar 100 Krivitt, V. & R.A. Good. 1956. Simultaneous occurrence of leukemia in mongols. Am. J. Dis. Child. 91: 218. 10.1001/archpedi.1956.02060020220002 Google Scholar 101 Francheschi, C., F. Licastro, M. Chiricoio, F. Bonetti, M. Zannotti, N. Fabris, E. Mocchegiani, M.P. Fantini, P. Paolucci & M. Masi. 1981. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome. J. Immunol. 126: 2161–2164. PubMedWeb of Science®Google Scholar 102 Zellweger, H. 1977. Down syndrome. In Congenital Malformations of the Brain and Skull. P. J. Vinken & G. W. Bruyn, Eds. Handbook of Clinical Neurology. Vol. 31: 367–470. Google Scholar 103 Gibbs, E.L., F.A. Gibbs & W. Hirsch. 1964. Rarity of 14- and 6-per second positive spiking among mongoloids. Neurology 14: 581. 10.1212/WNL.14.6.581 CASPubMedWeb of Science®Google Scholar 104 Dustman, R.E. & D.A. Callner. 1979. Cortical evoked responses and response decrement in nonretarded and Down's syndrome individuals. Am. J. Ment. Defic. 83: 391–397. CASPubMedWeb of Science®Google Scholar 105 Crapper, D.R., A.J. Dalton, M. Skopitz, J.W. Scott & V.C. Hachinski. 1975. Alzheimer degeneration in Down's syndrome. Arch. Neurol 32: 618–623. 10.1001/archneur.1975.00490510074006 PubMedWeb of Science®Google Scholar Citing Literature Volume396, Issue1Alzheimer's Disease, Down's Syndrome, and AgingOctober 1982Pages 15-27 ReferencesRelatedInformation